Interstitial lung disease (ILD) is a group of heterogeneous diseases with complex etiology, mainly manifested by interstitial inflammation and fibrosis of the lung, with more than 200 specific types, usually divided into 4 subgroups: ILD of known etiology, Idiopathic pulmonary fibrosis (IPF), granulomatous ILD and other forms of ILD, of which IPF is the most common, accounting for about 33.3%.
Conditions
Interventions
intervention group:Home symptom management
Sponsors
Fujian Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. ILD was first diagnosed by professional doctors based on their clinical manifestations, imaging examination (such as high-resolution CT), lung function tests and necessary histopathological examination; 2. After discharge, they choose to live at home and have not been admitted to a medical institution (such as a hospital or nursing institution); 3. Age >18 years old; 4.KPS function status score >= 60 points; 5. Have a smart phone device, and have the basic operation ability to skillfully use wechat for communication.
Exclusion criteria
Exclusion criteria: 1. Patients with serious complications or comorbidities, such as cardiovascular disease, liver and kidney failure; 2. Recent treatment that may affect the results of the study (such as lung transplantation, lung rehabilitation, etc.); 3. Complicated with malignant tumors or serious diseases of various important organs; 4. He is currently participating in or has participated in similar research projects.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| symptom distress; | — |
Secondary
| Measure | Time frame |
|---|---|
| dyspnea;quality of life;Exercise capacity;Self-management behavior;security; | — |
Countries
China
Contacts
Public ContactHuang Feifei
Fujian Medical University
Outcome results
None listed